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Abstract 
Pain elicits fear and anxiety and promotes escape, avoidance and adaptive behaviors 
that are essential for survival. When pain persists, motivational priority and attention 
shift to pain-related information, often resulting in impaired functionality, rendering 
pain-related fear and anxiety, escape and avoidance behaviors maladaptive. 
Neuroimaging studies in chronic pain patients, have established that brain activity, 
especially in cortical and mesolimbic regions, is different from activity observed during 
acute pain in control subjects. In this review, we discuss the psychophysiological and 
neuronal factors that may be associated with the transition to chronic pain. We review 
information from human studies on neural circuits involved in emotional and 
motivational pain processing and how these circuits are altered in chronic pain 
conditions. We then highlight findings from animal research that can increase our 
understanding of the molecular and cellular mechanisms underlying emotional-
motivational pain processing in the brain. Finally, we discuss how translational 
approaches incorporating results from both human and animal investigations may aid 
in accelerating the discovery of therapies. 
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1 A shift to negative emotional-motivational processing in chronic pain 
Pain is much more than the conscious perception of a sensory event. It is aversive and 
inseparably linked to emotion as reflected in the generally accepted definition of pain 
as “an unpleasant sensory and emotional experience associated with actual or 
potential tissue damage, or described in terms of such damage.“ (International 
Association for the Study of Pain, IASP; Loeser and Treede, 2008). In chronic pain, a 
high comorbidity with affective disorders such as depression and anxiety has been 
reported [2]. It has been hypothesized that in chronic pain a predominance of 
processing of negative emotional information might underlie emotional-motivational 
problems such as depression and anxiety. Research on pain has shifted in the last 
couple of decades from a strong focus on nociception toward a broader perspective 
that includes factors such as pain-relevant emotion and motivation that may 
contribute to the development and maintenance of chronic pain [3,4].  
A central feature of pain is that it is a strong stressor and motivator that can induce 
fear and anxiety and urges escape and avoidance responses. While acute pain is 
physiological, acting as an alarm system, preventing further damage and promoting 
behavior directed toward healing, fear, anxiety, and escape and avoidance responses 
become maladaptive in chronic pain, often resulting in impaired functionality, social 
withdrawal, anxiety, and depression [5]. The idea that chronic pain is related to a 
negative emotional-motivational shift, is intriguing, because it provides an 
explanation for dysfunctional processes related to reward, learning, goal regulation, 
and avoidance and approach behavior. However, investigating the mechanisms 
underlying a shift to negative emotional-motivational pain processing is challenging. 
Animal models allow important insights into neurobiological mechanisms, however, 
assessment of emotional-motivational aspects of pain is not comprehensive. In 
contrast, subjective experiences can be easily assessed in humans, but uncovering 
underlying neurobiological mechanism is more difficult. Translational approaches 
offer benefits linking these two domains.  
In this review, we focus on emotional-motivational factors possibly underlying a shift 
towards negative processing in chronic pain, bringing together information from 
animal and human research. Reward processing, learning, goal regulation, and related 
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pain avoidance behavior are such factors that seem to play a prominent role in pain 
and that are likely altered in the proposed shift. Possible synergies of translational 
research are highlighted, along with approaches on how preclinical research can be 
informed by human studies and vice versa. 
2 Human studies to investigate an emotional-motivational shift towards 
negative affective states in chronic pain 
Human behavior is directed by goals in a broad array of domains (e.g., social, work-
related, health). Thus, understanding an individual's response to acute and ongoing 
pain requires thorough examination of the motivational dynamics between this pain 
and other demands. Self-regulation theories, describing the processes by which one 
attempts to gain control over behavior, thoughts, feelings, desires, and actions in the 
service of goal attainment [6,7] provide useful insights into a range of phenomena 
including avoidance behavior and attentional processes [8]. An important aspect of 
self-regulation is how people modulate negative states, including pain, in the process 
of goal pursuit. Ongoing pain is often perceived as a barrier to the pursuit of valued 
goals [9]. The presence of ongoing pain results in perceived or anticipated 
discrepancies between actual and desired behavioral outcomes, resulting in negative 
affect. In an early state, patients with persistent pain are often motivated to stay 
committed to earlier (pre-pain) life goals and performance standards [10]. This is 
reflected by task persistence despite pain, which requires cognitive shielding and 
effort mobilization [11]. For example, attention will be focused on goal-relevant 
information, whereas distracting pain information will be inhibited [12]. In case of 
repeated goal failure, however, a motivational shift towards pain-related goals might 
occur, which often become a very dominant goal in patients' goal hierarchy. 
Individuals then prioritize effort towards goals such as getting rid of or acquiring 
control over the ongoing pain problem, which is often reflected by increased problem-
solving attempts and avoidance behavior [13], which are often maladaptive in ongoing 
and chronic pain. Such motivational shift is typically associated with a narrowed focus 
of attention toward pain-related information, increased accessibility of negative 
information, and worrying [10,14]. Repeated failure of problem-solving attempts and 
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attainment of valued goals might, at some point, start inducing feelings of 
helplessness and hopelessness, and associated states of depression and anhedonia. 
According to Brandtstädter and Rothermund (2002) [11], such (temporary) states may 
be adaptive, because they urge re-appraisal of the current situation and 
disengagement from inefficient effort mobilization to unattainable goals. Goal 
disengagement is reflected by devaluation of blocked goals, acceptance, and a shift of 
attention from narrowly focused and top-down towards more holistic, broad-based 
and bottom-up, allowing activation of alternative goals that may be more feasible and 
less affected by pain.  
In addition to goal-regulation, self-regulation theories consist of many factors, such as 
reward processing, learning, and approach and avoidance. All these factors, in 
themselves, have suggested mechanisms likely involved in an emotional-motivational 
shift in chronic pain. For example, reward processing has been dissected into 
dissociable components of wanting, i.e. the motivation to obtain a reward, and liking, 
i.e. the hedonic experience of such a reward [15]. Both components can be 
differentially affected by pain [16,17]. Pain has been reported to increase wanting 
while leaving liking unaltered [5,18]. This mismatch may reflect a drive to compensate 
for a negative emotion induced by pain, but being unsuccessful to increase pleasure. 
In chronic pain, a similar mismatch could represent unsuccessful coping attempts and 
the lack of increased pleasure following ‘trying harder’ could potentially lead to 
phenomena like learned helplessness (cf. [16]). Learning comprises several processes 
that are mechanistically very different in promoting behavior and/or perception. For 
example, operant learning results from the consequences of a behavior where the 
desired consequences lead to an increase in the probability that preceding behavior 
will be shown again (i.e., reward), while undesired consequences lead to a decrease 
of this probability (i.e., punishment)  [19]. In contrast, respondent or Pavlovian 
learning is the process, by which a formerly neutral stimulus comes to elicit a response 
that is similar as a response elicited by a naturally meaningful stimulus. Pain is a 
meaningful stimulus, eliciting, among other reactions, fear. If this pain is repeatedly 
coupled to a neutral stimulus, for example, a specific situation or movement (which 
does not cause the pain directly), this conditioned stimulus (CS) can then elicit fear 
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[20]. Approach and avoidance can be the results of such learning. For example, one 
can learn to avoid pain- or fear-inducing situations. Avoidance leads to particularly 
robust behavior. Because of avoidance a person does not experience that a feared 
stimulus is no longer harmful or threating, potentially delaying recovery. Such 
processes are well known in pain [21,22]. 
The theoretical framework presented here, providing insight in how people struggle 
to make sense of unwanted experiences, and how they avoid, adapt, or alter the 
perceived causes of those experiences, offers an excellent starting point to investigate 
emotional-motivational shifts in chronic pain at behavioral and psychobiological levels 
in humans. These processes are related to subjective experience and higher cognitive 
function, rendering human research an essential part in advancing knowledge on the 
emotional-motivational shift in chronic pain. 
2.1 Research in healthy volunteers 
Reward processing 
Pain and reward or pleasure have been suggested to be the two ends of a continuum, 
with emotion as a common currency that allows the comparison between stimuli (cf. 
[23]. This assumption suggests that pain and reward/pleasure affect each other. 
Indeed, pleasure and appetitive motivation induced by pleasant odors, pictures, or 
music as well as monetary rewards, inhibit acute pain [24–27]. An interesting case of 
reward is pain relief. Pain relief is strongly sought-after when in pain and can become 
an all-dominant goal in chronic pain. Relief from an aversive state is generally 
associated with rewarding experiences. For example, food tastes better when one is 
hungry [28,29] and the pleasure of pain relief is known to almost everybody. In line 
with the results on effects of pleasure and (monetary) reward on pain perception, pain 
relief as reward induces endogenous pain inhibition over and above the physical pain 
reduction [30]. 
The idea of a hedonic continuum with pain and reward/pleasure at its ends is 
supported by the observation that brain processing of pain and reward widely overlap 
[31]. But, only few studies so far investigated the mediating mechanisms between 
interactions of pain and reward. One study demonstrated that dopamine mediates 
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pain inhibition induced by reward [27]. Dopamine mediated not only the pain-
inhibiting effects of reward, but also the pain-facilitative effects of punishment 
suggesting that dopamine mediates motivated behavior triggered by stimuli of 
positive and negative valence (cf. [32]). With respect to endogenous opioid activation, 
it has been observed that responses in the periaqueductal gray and ventral striatum 
to rewarding stimuli at the age of 14 years predicted the presence of pain complaints 
in adolescents two years later, with much stronger effects for carrier of the T-allele of 
the rs563649 polymorphism of the human mu-opioid receptor (OPRM1) gene [33]. 
Carriers of the T-allele of this polymorphism shown increased responsiveness to a 
number of noxious stimuli, including ischemic, mechanical, and thermal stimuli 
applied to various anatomical sites [34]. At the circuit level, the orbitofrontal cortex 
mediates reward-induced pain inhibition through altered functional connectivity with 
the rostral anterior insula, anterior-dorsal cingulate cortex and primary 
somatosensory cortex [35]. In line with these results, Talmi and colleagues [36] 
showed that increased activation in the insula was associated with prioritizing pain 
avoidance over obtaining a monetary reward and this increased activation was related 
to increased activation in the orbitofrontal cortex. Pain relief (although not 
implemented as reward) is associated with increased activation in the nucleus 
accumbens as well as in the ACC [37–39]. The ACC has a high density of opioidergic 
receptors, leading to the hypothesis that opioidergic mechanisms in the ACC might be 
related to the endogenous pain inhibition related to rewarding pain relief, which is 
supported by preclinical studies (see below). In humans, this was demonstrated by 
positron emission tomography (PET) showing an association of opioidergic receptor 
activation in the ACC with perceived reductions in pain induced by placebo 
interventions [40–42]. 
Learning 
Learning processes can affect the pain experience via different routes. One possibility 
is through operant learning, i.e. learning based on reward, affecting the perception of 
pain. Few studies investigated this route by using e.g. verbal reward in terms of praise 
to increase or decrease participants’ ratings of experimental pain [43,44]. However, it 
is conceivable that in those studies only participants’ rating behavior was changed (as 
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this was what was reinforced), but not necessarily the perception of pain. But, by 
operant learning also pain-related evoked brain potentials [45] and facial pain 
expression [46] can be increased or decreased. Instead of using extrinsic 
reinforcement, such as verbal reinforcement or smileys, pain relief can be used as 
intrinsic reinforcement, i.e. within the pain system. As such, rewarding pain relief 
appears particularly well suited to induce operant learning processes, which has been 
shown in several studies, confirming that (partial) pain relief can lead to learned 
changes in pain perception in humans [47–49] and in animals (e.g. [50]; see section 3 
below).  
A different route is fear learning that affects pain processing. Learned fear of pain is 
related to facilitated sensitization and decreased thresholds for pain [51–53], 
interference with habituation to repeated pain stimuli  [54], enhanced somatosensory 
processing at pain-relevant body locations [55,56], and impaired acuity of perceptual 
discrimination [57]. Pain-related fear conditioning has also been shown to induce 
increased tension in muscle responses [58]. 
Goal-regulation, approach and avoidance 
The effect of motivational context on pain processing has been the topic of increasing 
experimental research endeavors. For instance, it has been demonstrated that 
experimentally inducing the goal of pain avoidance in healthy volunteers significantly 
enhanced existing attentional biases to visual cues signaling imminent pain [59]. 
Durnez and Van Damme (2015) [60] found that experimentally induced expectation 
of pain on a specific body location enhanced somatosensory processing at that body 
location relative to other locations in a Tactile Change Detection (TCD) task, especially 
in participants who were motivated to actively avoid painful stimulation by a specified 
motor action. Durnez and Van Damme (2017) [61] further demonstrated that, using 
similar experimental manipulation of motivation, participants actively attempting to 
avoid pain, showed prioritization of somatosensory stimuli over visual stimuli in a 
bimodal Temporal Order Judgment (TOJ) task. It has also been found in an 
experimental study with healthy volunteers that, after losing control over pain 
administration, persistent attempts to re-gain control were associated with more fear 
of pain and performance costs on a secondary cognitive task, suggesting narrow 
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attentional focus on pain [62]. All this experimental work suggests that alterations in 
goal priorities, such as a strong motivational focus on pain control or avoidance, might 
substantially enhance attentional focus on pain. 
Some experimental work studying the effects of competition between pain-related 
goals and non-pain goals is available. It has been shown that concurrent pursuit of a 
salient goal significantly reduced attentional bias towards visual cues signaling 
impending experimental pain [63]. Furthermore, Karsdorp, Schrooten, and Geenen 
(2017) [64] used a dot probe paradigm to assess attentional bias in which stimuli 
predicting experimental pain were put in competition with stimuli associated with a 
temporary non-pain goal. They found preferential attending to goal-related 
information over pain-related information, especially in those participants high in self-
reported trait attentional control. Furthermore, increasing the motivational salience 
of a distraction task during cold pressor pain, enhanced distraction effectiveness, 
particularly in participants scoring high on catastrophic thinking about pain [65]. There 
is also increasing evidence that induction of a non-pain goal may counteract pain-
related avoidance behavior. In a study by Van Damme and colleagues (2012) [66] 
healthy volunteers were presented trials of two different tasks, of which one could 
result in the administration of a painful stimulus, and they were free to perform or not 
these trials. In half of the sample, a competing goal was induced by instructing 
participants that they could win monetary rewards by performing the pain task. The 
findings showed that this competing goal resulted in less avoidance of the painful task, 
and in a significant reduction of the association between fear of the pain stimulus and 
avoidance of the painful task. Similar findings were reported in a study by Claes, and 
colleagues (2014) [67]. Using a voluntary joystick paradigm, they conditioned one 
movement to be pain-inducing and another movement to be safe. In half of the 
sample, the pain-inducing movement was also associated with obtaining a financial 
reward. In those participants, the pain-related movement was performed more 
frequently, and the typical slowing of movements signaling pain was attenuated, 
although pain-related fear remained unaltered. These findings were replicated in a 
study by Claes, Crombez, and Vlaeyen (2016) [68]. They used the same procedure, but 
additionally categorized participants based upon their self-reported goal priority 
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(avoiding pain versus seeking reward), and found that the effect of the concurrent 
goal on pain avoidance behavior was most pronounced in those participants who 
prioritized reward seeking, and less pronounced in those participants prioritizing pain 
avoidance. This is also in line with another study which experimentally manipulated 
goal pursuit during the performance of cognitive tasks while being exposed to pain, 
and found that participants persisted longer in an achievement relative to a hedonic 
(avoiding pain) goal context [69]. 
2.2 Research in chronic pain patients 
Reward processing 
Although studies are still scarce, research suggests changes in brain functions in 
individuals with chronic pain (for review see e.g., [3,70]). Impairment of reward-
related decision-making has been reported in patients with chronic back pain and 
complex regional pain syndrome (CRPS) [71]. Studies have shown that chronic pain is 
likely to be accompanied by a hypodopaminergic state (for review see [32]). A 
decrease in D2-receptor binding [72–75] and presynaptic activity [76,77] in the 
striatum has been observed at rest and after painful stimulation in humans using PET. 
This might also play a critical role in chronic pain. Further, altered responses in the 
nucleus accumbens to the cessation of a painful stimulus was found in patients with 
chronic pain versus healthy controls using fMRI [37]. Moreover, variations of the 
activity in the nucleus accumbens during reward processing significantly predicted 
anhedonia, i.e. the inability to perceive pleasure, which has been suggested to be 
associated with chronic pain in some patients independent of depression [78,79]. In 
addition, chronic pain patients have been shown to exhibit less robust activation in 
brain regions associated with affective and cognitive pain-modulatory processes, 
specifically the ventral tegmental area, to the anticipation of pain (pain onset) and the 
anticipation of pain relief (pain offset) [80]. 
Learning 
The few available data on respondent conditioning in patients with chronic pain 
suggest that pain responses can be easily conditioned on multiple levels of the 
nervous system, can lead to enhanced pain perception and maladaptive brain changes, 
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and that chronic pain patients acquire conditioned fear responses faster and 
extinguish them more slowly [58,81,82]. In patients with chronic low back pain 
compared to healthy individuals, a positive correlation of brain responses in the 
amygdala and insula and their connectivity with conditioned fear of movement has 
been observed [83]. Moreover, in patients with irritable bowel syndrome (IBS) 
compared to healthy individuals increased cerebellar responses to both pain-
associated and safety conditioned stimuli (CSs) during fear learning have been found. 
With respect to fear extinction, chronic pain may be characterized by impaired 
extinction of pain-related fear generalization [84] and enhanced reactivations of 
extinguished conditioned fear responses [85–87]. This may indicate a preservation of 
pain disability in chronic pain by persistent excessive protective behavior, which 
seems to be related to an individual's awareness of the association between the CS 
and the pain, which is the unconditioned stimulus [88,89]. 
Moreover, along an operant conditioning model of pain [90], increases or decreases 
of pain perception can serve as implicit reinforcers: In this context, fibromyalgia 
patients without comorbid IBS did not learn pain habituation, but showed increased 
sensitization compared to healthy controls, and those with comorbid IBS showed 
neither sensitization nor habituation learning [49]. Mechanisms of operant 
conditioning of sensitization or habituation may thus be differentially altered in 
chronic pain. 
In addition, respondent and operant processes interact and may induce motivational 
biases forming habitual behaviors and a shift from more ventral to dorsal striatal 
circuits similar to addictive processes [91]. Thus, in chronic pain, fear of pain may then 
motivate behaviors that lead to pain relief, which is experienced as rewarding. 
However, this still needs to be tested in an experimental fashion. Moreover, brain 
changes during fear conditioned predictions such as reduced PFC responses during 
extinction learning may hinder learning of new predictive stimulus properties. This 
includes those that are important to reduce pain and could thus contribute to the 
development and persistence of chronic pain, but also this still needs to be 
determined. 
Goal-regulation, approach and avoidance 
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One of the most significant alterations resulting from chronic pain conditions is the 
disruption of appropriate and valued (goal-directed) behavior (e.g., [92–94]). Changes 
in approach and avoidance tendencies are discussed as central components in the 
development and maintenance of chronic pain (e.g., [95]). The competition between 
pleasure-related cues and pain can drive decisions and guide approach or avoidance 
behavior, which can already be observed at stages of acute pain. Pain-related fear 
needs to be considered within a motivational context to avoid or control pain with 
often competing existing goals (e.g., [10,13,96–100]). Patients with chronic pain often 
experience difficulties in weighing the value of pain avoidance versus the withdrawal 
from valued activities (e.g., [16,101–103]). This would be especially important in the 
case when pain relief becomes more important than other rewards. 
Correspondingly, it has been proposed that individuals with chronic pain are often 
stuck in (largely unsuccessful) attempts to get control over their pain [14], and that 
this makes them chronically vigilant to pain-related information [104]. A recent study 
indicated that individuals with chronic pain give indeed high priority to pain control 
goals and often see pain control as a necessary condition to attain other goals [105]. 
There is also accumulating evidence that chronic pain patients might be characterized 
by biased attention to pain-related information [106]. However, empirical research on 
the link between shifts in motivational priority and attentional processing, is scarce 
[12]. One study, though, showed that a strong focus on problem-solving attempts 
towards pain was associated with more catastrophic thinking about pain and greater 
attention to pain [107].  
3 Preclinical investigations of emotional-motivational pain processing 
Although most animal studies of pain rely on measurements of evoked mechanical 
and thermal responses, the need for evaluation of affective/motivational and 
cognitive aspects of pain and the underlying molecular, cellular and circuit 
mechanisms is increasingly being recognized [108]. Complementary to human studies, 
animal investigations have demonstrated a critical role of corticolimbic circuitry in the 
processing of acute and chronic pain, which is involved in the evaluation of changing 
goals and competing motivations and facilitates decisions on avoidance, coping and 
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adaptive behavior. During acute pain states, corticolimbic circuitry promotes self-
regulation of pain [109] through the engagement of descending pain modulatory 
pathways or through the inhibition of the affective/emotional response to pain. 
Animal studies of pain motivated behavior 
Mesolimbic reward/motivation circuitry, consisting of dopaminergic neurons in the 
ventral tegmental area and their projections to the nucleus accumbens in the striatum, 
is activated by rewards including food, drink, warmth etc. and by drugs of abuse. 
Electrophysiological studies in animals, typically demonstrate inhibitions of midbrain 
dopamine neurons by aversive stimuli, consistent with the role of these neurons in 
reward coding [110–112]. However, a proportion of dopaminergic neurons can be 
excited by noxious or alerting stimuli [113–115]. In addition, some reward coding 
dopamine neurons were found to increase their activity at the offset of a noxious 
stimulus [116,117], suggesting a “rebound” response to relief of pain. Therefore, 
mesolimbic neurons respond to alerting, aversive and rewarding stimuli, including 
relief reward [118], and encode their salience and motivational value. These 
heterogeneous populations of neurons project to different brain regions in the 
striatum, prefrontal cortex, hippocampus and amygdala to initiate specific motivated 
behavior and to promote learning. 
Recently, measurements of dopamine transients in response to painful pinch of the 
rat’s tail, using fast scan cyclic voltammetry (FSCV) demonstrated increased dopamine 
release in the dorsal striatum and in the core of the nucleus accumbens [119], 
suggesting saliency coding. In contrast, dopamine levels were suppressed during the 
painful stimulus in the shell region of the nucleus accumbens, and increased after pain 
offset [119,120]. Behavioral studies in rats with sustained post-surgical, neuropathic, 
inflammatory or bone cancer pain demonstrate that relief of pain with non-opioid 
interventions elicits conditioned place preference (CPP) only in injured but not sham-
operated animals [50,121–127]. These findings demonstrate that pairing of the pain-
relieving treatment with a CPP chamber, provides a learning experience and promotes 
motivation to seek pain relief. CPP is accompanied by release of dopamine in the NAc, 
and blockade of dopamine receptors in the nucleus accumbens blocks CPP from pain 
relief [50]. These studies establish the role of mesolimbic dopamine signaling in pain 
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and pain relief as alerting and emotional signals that promote learning and shape 
behavioral response.  
Aversive aspects of pain 
The prefrontal cortex (PFC) plays a major role in motivated behavior, decision-making, 
emotional processing and cognition and is therefore critically involved during acute 
and chronic pain. The PFC provides top down control of the sensory and affective 
dimensions of pain and has functional connections with the mesolimbic dopamine 
circuitry, amygdala and hippocampus. In rodents, PFC can be subdivided into the 
anterior cingulate (ACC), prelimbic (PL) and infralimbic (IL) cortices, each providing 
unique pain modulatory functions. In the ACC, long-term potentiation (LTP) is believed 
to enhance pain responses and facilitate the interaction between chronic pain and 
anxiety [128]. Optogenetic stimulation of the inhibitory neural circuitry of the ACC 
leads to decreased neuronal activity in the ACC and reduction in pain behavior [129]. 
Pharmacological studies demonstrating CPP in rats with neuropathic pain following 
microinjection of morphine in the ACC indicate that these pain inhibitory circuits are 
likely the targets of exogenous opioid analgesics [130]. In addition, blockade of opioid 
ACC circuits prevented CPP elicited by non-opioid therapy, suggesting that 
endogenous opioid ACC circuits may be necessary for relief of pain aversiveness in 
general [130].  
In the rodent PL, chronic neuropathic pain was shown to inhibit firing of pyramidal 
neurons as a result of feed forward inhibition mediated by GABAergic interneurons 
[131]. Consequently, optogenetic activation of parvalbumin-positive GABAergic 
neurons decreased pain responses and produced CPP, while optogenetic inhibition of 
these cells increased pain responses. Moreover, antinociceptive effects were also 
observed following selective activation of the projections from PL to NAc, suggesting 
regulatory role of the PL on mesolimbic dopamine circuitry and affective/motivational 
symptoms of pain [132].  
The PFC also receives reciprocal inputs from the amygdala and the hippocampus, the 
brain regions essential for consolidation of emotional memories and fear conditioning. 
Synaptic plasticity in both regions has been observed in rodent models of neuropathic 
pain [133,134]. Deactivation of the PFC through increased inputs from the basolateral 
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amygdala has been demonstrated in a model of arthritic pain [135,136]. Conversely, 
the PFC projects to, and modulates the activity of a specific population of inhibitory 
cells in the amygdala, the intercalated cells, that control the function of amygdala pain 
output cells. However, more research needs to be done to unravel the precise neural 
circuitry that drives specific pain-related behavior. 
Preclinical research therefore supports a critical role of the corticolimbic neural 
circuits involving endogenous dopamine and opioid neurotransmission in adaptive 
behavior, learning and decision making in the context of pain [137]. Corticolimbic 
circuits integrates pain-related experiences with other competing motivational goals, 
allows evaluation of the costs and benefits and underlies selection of appropriate 
behavioral actions. The reported results in animals are therefore well in line with 
result in humans. The engagement of corticolimbic circuits in endogenous pain 
adaptive mechanisms also implies that diminished ability of these circuits to control 
emotional pain processes may underlie the transition to chronic pain [138].  
Aberrant corticolimbic circuitry and transition to chronic pain 
Animal pain studies are typically conducted at early times following injury (less than 
one month) and cannot be classified as truly chronic and analogous to chronic pain 
conditions in patients. However, several recent studies have extended this time period 
in order to identify neural mechanisms that occur late after the initial insult and may 
therefore represent mechanisms underlying the shift from sensory to emotional pain 
processing. Seminowicz et al [139,140] have investigated pain behavior and brain 
changes during a 4 months period following nerve injury in rats. At this late time point 
they observed the emergence of anxiety behavior that coincided with the occurrence 
of volumetric changes in the PFC of injured rats. It is likely, that molecular and cellular 
modifications in the brain precede these larger-scale volumetric changes and the 
emergence of co-morbid behaviors such as anxiety, depression and cognitive 
impairments. Indeed, expression of genes encoding dopamine and kappa opioid 
receptors in the rat nucleus accumbens was reduced 28 days but not 5 days following 
nerve injury [141]. Coincidently with these molecular changes, altered functional 
connectivity between the NAc and dorsal striatum and cortex was also observed only 
at the later time point. Moreover, fMRI BOLD activity in the NAc and prefrontal areas 
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was associated with tactile allodynia on day 28 after nerve injury [142]. Therefore, 
reorganization of the brain during transition from acute to chronic pain has been 
demonstrated in animal pain models. These preclinical investigations are beginning to 
identify molecular underpinnings of the shift from nociceptive to emotional pain 
processing in chronic pain. 
4 Translation of preclinical findings to clinical applications 
Research in animals allows invasive mechanistic investigations that can be performed 
in a relatively homogenous population under calibrated and controlled conditions 
without the interference of confounding factors such as use of medications, different 
life styles, etc. present in human studies. Animal research has significantly contributed 
to our understanding of basic anatomy and neural mechanisms of pain processing. For 
example, the descending opioid-sensitive pain modulatory pathways from the 
periaqueductal grey area (PAG) and rostral ventromedial medulla (RVM) were first 
identified in rodents and cats [143–145]. It was later discovered that electrical 
stimulation of PAG produced naloxone-reversible analgesia in patients with 
intractable pain [146,147]. This success in predicting clinical responsiveness based on 
preclinical findings demonstrates translational relevance of animal research. However, 
limitations of animal research must also be acknowledged.  
First, animal pain models cannot directly replicate the full complexity of the human 
pain experience and are intended to inform about potentially important neural 
mechanisms. Second, animal research is conducted in homogenous populations, 
offering an advantage in robustness of the effect size, but also potentially limiting the 
generality of the effect. Several examples have shown differences in pain responses 
between different species or even between different rodent strains [148,149]. 
Another obstacle specifically in investigating chronification of pain in animals is the 
relative inability to assess pain-related emotional states. Researchers have used open-
field, forced-swim, or elevated plus-maze tests to evaluate anxiety- and depressive-
like behaviors in animals with persistent pain [150,151]. Burrowing, home-cage 
monitoring, and voluntary wheel running have been used to assess the well-being of 
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animals [152,153]. Recently, operant assays such as conditioned place 
preference/avoidance [154] and place escape avoidance paradigm (PEAP) [155] were 
adopted to evaluate affective-motivational aspects of acute and ongoing pain. 
Although these measures are indirect and limited in comparison to the whole array of 
affective, emotional, and well-being assessments available in human research, they 
provide important mechanistic information about emotional-motivational and 
cognitive aspects of pain. An important issue for future research is thus to increase 
correlation between human and animal studies. Such complementary research is 
necessary to identify the cellular and molecular mechanisms that promote transition 
to chronic pain and determine whether these mechanisms can be targeted 
therapeutically. 
Conclusions  
Chronic pain is different from acute nociception or subacute persistent pain. 
Unrelenting pain loses its alerting and motivational utility and becomes a constant 
burden that disrupts goal-directed behavior. Patients with chronic pain are often more 
vigilant to pain-related information and shift their motivational priority to pain control 
goals. The affective and motivational disturbances play a critical role in reward, 
learning and information processing, goal regulation, and avoidance behavior. These 
observations suggest a complex interplay between motivational and emotional 
factors, whose interrelations and relevance shift in chronic pain. Related variables 
such as valuation of stimuli, desires and needs vary largely inter- and intra-individually 
depending on a specific situation.  
Consistent with these psychological signs of chronic pain patients, neuroimaging 
studies have demonstrated changes in brain anatomy and function, that generally 
reflect a shift from predominantly nociceptive to more affective and emotional 
processing [156]. Altered structure and function in emotional-motivational fronto-
striatal brain circuits have been shown to predict the transition from subacute to 
chronic back pain. Specifically, increased functional connectivity in between the 
nucleus accumbens and the ventromedial PFC predicted this transition [157] as well 
as higher incidence of white matter and functional connections between medial 
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prefrontal cortex, NAcc, and amygdala [138,158]. Both these functional and structural 
alterations predicted pain persistence over one year, suggesting that the development 
of chronic pain is predetermined by neuroanatomical and -functional factors outside 
core nociceptive processes. Importantly, the relevance of non-nociceptive fronto-
striatal circuits in pain modulation has been confirmed in healthy volunteers [109,159]. 
Adding these results, altered dopamine and opioid activity have been shown using PET 
imaging. Research in humans, however, is limited when it comes to the investigation 
of underlying neurophysiological mechanisms. Despite great advances in technical 
possibilities, brain imaging is still restricted to a coarse resolution compared to the 
density of neurons and invasive procedures are only possible in very rare cases.  
Animal research has confirmed the role of corticolimbic circuits in affective and 
motivational aspects of pain and provided more fundamental insights into 
neurobiological mechanisms. Thus, electrophysiological, FSCV and behavioral 
measurements demonstrate a role of dopamine signaling for pain and pain relief. 
Other investigations show the requirement of endogenous opioid activity in the ACC 
for relief of pain following opioid or non-opioid therapy. With the development of new 
techniques, including genetic approaches, it is now possible to investigate the impact 
of chronic pain on specific cells in neuronal circuits. Translationally relevant animal 
models and measures that are based on clinical observations will be able to provide 
mechanistic insights into neural circuitry in chronic pain and help to identify novel 
therapeutic options for patients. 
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